Voronkov M[au] - Search Results

Year	Number of Results
1969	1
1971	1
1973	1
1974	1
1975	1
1976	3
1979	2
1982	3
1983	3
1984	2
1985	2
1986	1
1987	3
1988	2
1989	4
1990	9
1991	3
1992	8
1993	6
1994	3
1995	5
1996	4
1997	1
1999	2
2000	5
2001	4
2002	4
2003	3
2004	1
2005	2
2006	2
2009	3
2010	4
2011	8
2012	4
2013	2
2014	4
2015	2
2016	3
2017	2
2018	5
2019	1
2020	3
2021	4
2022	2

1

NB-33, a bioreversible opioid derivative of Nalbuphine, shows enhanced pharmacodynamics.

Voronkov M, Nikonov G, Naumov R, Abernethy J, Isakulyan L. Voronkov M, et al. Eur J Pharm Sci. 2021 Apr 1;159:105734. doi: 10.1016/j.ejps.2021.105734. Epub 2021 Jan 27. Eur J Pharm Sci. 2021. PMID: 33515698

2

Does a hypoxic injury from a non-fatal overdose lead to an Alzheimer Disease?

Voronkov M, Cocchiaro B, Stock JB. Voronkov M, et al. Neurochem Int. 2021 Feb;143:104936. doi: 10.1016/j.neuint.2020.104936. Epub 2020 Dec 10. Neurochem Int. 2021. PMID: 33309980 Review.

3

A vicious cycle of neuropathological, cognitive and behavioural sequelae of repeated opioid overdose.

Voronkov M, Ataiants J, Cocchiaro B, Stock JB, Lankenau SE. Voronkov M, et al. Int J Drug Policy. 2021 Nov;97:103362. doi: 10.1016/j.drugpo.2021.103362. Epub 2021 Jul 24. Int J Drug Policy. 2021. PMID: 34314956 Review.

4

Cardiac mitochondrial function depends on BUD23 mediated ribosome programming.

Baxter M, Voronkov M, Poolman T, Galli G, Pinali C, Goosey L, Knight A, Krakowiak K, Maidstone R, Iqbal M, Zi M, Prehar S, Cartwright EJ, Gibbs J, Matthews LC, Adamson AD, Humphreys NE, Rebelo-Guiomar P, Minczuk M, Bechtold DA, Loudon A, Ray D. Baxter M, et al. Among authors: voronkov m. Elife. 2020 Jan 15;9:e50705. doi: 10.7554/eLife.50705. Elife. 2020. PMID: 31939735 Free PMC article.

5

Modifying naloxone to reverse fentanyl-induced overdose.

Voronkov M, Nikonov G, Ataiants J, Isakulyan L, Stefanut C, Cernea M, Abernethy J. Voronkov M, et al. Int J Pharm. 2022 Jan 5;611:121326. doi: 10.1016/j.ijpharm.2021.121326. Epub 2021 Nov 27. Int J Pharm. 2022. PMID: 34848365

6

Biological activity of silatranes.

Voronkov MG. Voronkov MG. Top Curr Chem. 1979;84:77-135. doi: 10.1007/BFb0048523. Top Curr Chem. 1979. PMID: 388722 Review. No abstract available.

7

Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's disease.

Voronkov M, Braithwaite SP, Stock JB. Voronkov M, et al. Future Med Chem. 2011 May;3(7):821-33. doi: 10.4155/fmc.11.47. Future Med Chem. 2011. PMID: 21644827 Free PMC article. Review.

8

Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's disease.

Braithwaite SP, Voronkov M, Stock JB, Mouradian MM. Braithwaite SP, et al. Among authors: voronkov m. Neurochem Int. 2012 Nov;61(6):899-906. doi: 10.1016/j.neuint.2012.01.031. Epub 2012 Feb 8. Neurochem Int. 2012. PMID: 22342821 Review.

9

HYVIA™: A novel, topical chia seed extract that improves skin hydration.

Huber KL, Fernández JR, Webb C, Rouzard K, Healy J, Tamura M, Voronkov M, Stock JB, Stock M, Pérez E. Huber KL, et al. Among authors: voronkov m. J Cosmet Dermatol. 2020 Sep;19(9):2386-2393. doi: 10.1111/jocd.13469. Epub 2020 May 27. J Cosmet Dermatol. 2020. PMID: 32378329 Clinical Trial.

10

Zitramin-a new antidote for acute ethanol intoxication.

Voronkov MG, Yushkov GG, Mashanov AV, Fedorin AY, Rasulov MM, Benemansky VV, Kuznetsova GA. Voronkov MG, et al. Dokl Biochem Biophys. 2013 Jul-Aug;451:215-6. doi: 10.1134/S1607672913040170. Epub 2013 Aug 23. Dokl Biochem Biophys. 2013. PMID: 23975405 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results